About MaxWell Biosystems
MaxWell Biosystems is a company based in Basel (Switzerland) founded in 2016. MaxWell Biosystems has raised $4.64 million across 15 funding rounds from investors including Sensirion, European Union and Venture Kick. MaxWell Biosystems operates in a competitive market with competitors including Quiver Bioscience, Forcyte Biotechnologies, Novoheart, Multi Channel Systems and Relitect, among others.
- Headquarter Basel, Switzerland
- SectorsHealthcare
- Email••••••••
- Website mxwbio.com
- Social LinkedIn X YouTube
- Legal Name Maxwell Biosystems Ag
- Total Equity Funding$4.64M (USD)
in 15 rounds
- Latest Funding Round$466.63K (USD), Grant
Jun 2021
- InvestorsSensirion
& 4 more
Apps and channels of MaxWell Biosystems
its YouTube channel MaxWell Biosystems has 125 subscribers and 22 videos.
Videos from MaxWell Biosystems
The most watched videos on MaxWell Biosystems's YouTube channel, MaxWell Biosystems (125 subscribers). Click a video to play it here.
More on MaxWell Biosystems.
Funding Insights of MaxWell Biosystems
MaxWell Biosystems has successfully raised a total of $4.64M across 15 strategic funding rounds. The most recent funding activity was a Grant round of $466.63 thousand completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.64M
- Total Rounds 15
- Last Round Grant — $466,634
- First Round $20,065
(Nov 2016)
- Investors Count 5
Latest 10 of 15 funding rounds of MaxWell Biosystems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2021 | $466,634 | Grant | – | – | |
| Dec 2020 | $4.51M | Series A | – | Sensirion | |
| Mar 2020 | $149,515 | Grant | – | – | |
| Dec 2019 | $535,052 | Grant | – | – | |
| Oct 2019 | $149,515 | Grant | – | – | |
| Sep 2019 | $230,309 | Grant | – | – | |
| Jul 2019 | $55,732 | Grant | – | – | |
| Feb 2019 | $230,309 | Grant | – | – | |
| Feb 2019 | $56,588 | Grant | – | – | |
| Jan 2019 | $535,052 | Grant | – | – |
5 investors in total: 5 institutional.
Investors in MaxWell Biosystems
MaxWell Biosystems has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Sensirion, European Union and Venture Kick.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
University backed startup accelerator | – | venturekick.ch | Schlieren, Switzerland | |
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Sensors for humidity, gas, and liquid flows are developed. | 1998 | sensirion.com | Zurich, Switzerland | |
A platform for recognizing and promoting innovative Swiss startups. | 2011 | top100startups.swiss | Schlieren-Zürich, Switzerland |
Investor details for MaxWell Biosystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MaxWell Biosystems
39 people are tracked at MaxWell Biosystems (5 in leadership, 34 in team).
| Name | Role | Group |
|---|---|---|
Kim Schwendener | Head of HR & Finance | Leadership |
Jan Müller | CTO | Leadership |
Marcel Suter | VP, Operations | Leadership |
Urs Frey | CEO | Leadership |
Kim S. | Head Of HR And Finance | Leadership |
Juanita Schneiter | Operator | Team |
Kazu Okada | Inside Sales Representative | Team |
Peter Kaplan | IT Administrator & Software Engineer | Team |
Elvira Guella | Junior Scientist | Team |
Wei Zhu | China Business Manager | Team |
Vijay Viswam | R&D Project Manager | Team |
Praveena Manogaran | Scientific Team Lead | Team |
Zhuoliang Li | Field Application Scientist | Team |
Rebecca Lyttkens | Operator | Team |
Philipp Zappa | Development Engineer & Supply Chain Manager | Team |
Jérôme Zemp | Senior R&D Engineer | Team |
Endri Rama | Senior R&D Engineer | Team |
Marie Obien | CCO | Team |
Mengting Huang | Scientific Application Representative | Team |
Ferran Esquius Cano | Marketing & Lead Generation Coordinator | Team |
19 more people are available in the full profile.
Complete people profiles for MaxWell Biosystems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of MaxWell Biosystems
3 dated milestones of MaxWell Biosystems across 5 years, from founding to its latest funding, stage changes and deals.
- Founded MaxWell Biosystems is founded.
- Funding First funding round of $20K.
- Funding Latest funding round, Grant, of $467K.
Competitors of MaxWell Biosystems
MaxWell Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quiver Bioscience, Forcyte Biotechnologies, Novoheart, Multi Channel Systems and Relitect, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| quiverbioscience.com | 2013 | Cambridge, United States | – | – | Developer of transformational medicines for neurological disorders | |
| forcytebio.com | 2017 | Los Angeles, United States | $1.13M | – | Automated single-cell contractility screening systems are developed for drug discovery. | |
| novoheart.com | 2014 | Vancouver, Canada | – | – | Bioartificial hearts are engineered using stem cells and tissue methods. | |
| multichannelsystems.com | 1996 | Reutlingen, Germany | – | 68 | Tools and systems for electrophysiology are developed and supplied. | |
| relitect.com | 2014 | Lanark, United Kingdom | $1.13M | – | Label-free biomolecule detection is enabled via electrochemical impedance sensors. | |
| sysmex-europe.com | 1980 | Norderstedt, Germany | – | – | Sysmex Europe offers diagnostic instruments and services for healthcare laboratories worldwide. | |
| cytocybernetics.com | 2013 | Buffalo, United States | – | – | Electrophysiology tools such as patch clamp systems are developed. | |
| nanion.de | 2002 | Munich, Germany | – | – | Automated patch clamp platforms for electrophysiology are developed. | |
| functionalfluidics.com | 2013 | Detroit, United States | $3.58M | – | Microfluidics-based assays are developed for studying blood disorders. |
Detailed competitors of MaxWell Biosystems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MaxWell Biosystems
The website of MaxWell Biosystems (mxwbio.com) receives about 22.5K visits a month.
- Monthly visits22.5K
▼ 15.2% vs previous month
Websites whose visitors overlap most with MaxWell Biosystems. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| 3brain.com | 100% | 9.7K | #2,448,172 | View details | |
| multichannelsystems.com | 98% | 123.5K | #370,590 | View details | |
| axionbiosystems.com | 88% | 35.5K | #817,660 | View details | |
nips.ac.jp | nips.ac.jp | 76% | – | #816,309 | – |
| sinobiological.com | 61% | 188.9K | #224,370 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for MaxWell Biosystems
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Maxwell Biosystems
Complete news archive for MaxWell Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to MaxWell Biosystems
10 companies that operate in the same segment as MaxWell Biosystems (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MaxWell Biosystems
MaxWell Biosystems was founded in 2016.
MaxWell Biosystems is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
MaxWell Biosystems is a funded company, having raised a total of $4.64M across 15 funding rounds to date. The company's 1st funding round was a Grant of $535.05K, raised on Nov 2016.
MaxWell Biosystems was founded in 2016 in Basel, Switzerland, within the biotechnology sector. An in vitro assay platform centered on electrophysiology is developed, featuring the MaxOne system. This CMOS-based microelectrode array enables recording and stimulation of electrogenic cells from brain, retina, and heart tissues. Applications include phenotypic screening, single-cell analysis, network evaluation, drug efficacy assessment, and toxicity testing for research and pharmaceutical purposes.
MaxWell Biosystems's top competitors include Quiver Bioscience, Novoheart and Forcyte Biotechnologies.
MaxWell Biosystems has 5 investors. Key investors include Sensirion, European Union, Venture Kick, Top100 Swiss Startups, and EIC Fund.
MaxWell Biosystems operates through Maxwell Biosystems Ag.